Hensoldt AG (0A5S)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 84.30 |
|---|---|
| 52-week range | 63.16 – 96.74 |
| Return, 1 month / 3 months | +9.6% / +5.6% |
| Return, 1 year / 3 years | −11.5% / +207.9% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 45.7% |
| Worst drawdown (1 year) | -32.7% |
| Average daily value traded | 3.96M EUR |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hensoldt is a defence electronics company based in Germany that supplies sensors and electronic systems for military and security customers. Its work covers radar systems for surveillance and air defence, electronic warfare equipment, and optronics such as thermal imaging and sighting devices used on vehicles, aircraft and ships. It also provides support and maintenance services for these systems. Its main customers are armed forces and government security agencies, particularly in Germany and other European countries.
On this site Hensoldt AG appears as a stock on the London Exchange (UK), code 0A5S, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hensoldt AG (0A5S) trades on the London Exchange in UK. It last closed at EUR 84.30 on 21 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,915 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.5% and over the last three months it rose 5.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.5% | ||
| From 52-week high | -12.2% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.6% | ||
| 6-month return | 16.1% | ||
| 12-month return, skipping the last month | -19.3% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.7% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.96M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.4% |
|---|---|
| 1 month | +9.6% |
| 3 months | +5.6% |
| 6 months | +16.1% |
| 1 year | −11.5% |
| 3 years | +207.9% |
| 5 years | +538.5% |
Signals
| 50-day / 200-day average | 82.22 / 79.88 |
|---|---|
| Golden / death cross (60 days) | Golden, 46 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 3.20 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 May 2026 | EUR 0.5500 |
| 28 May 2025 | EUR 0.5000 |
| 20 May 2024 | EUR 0.4000 |
| 15 May 2023 | EUR 0.3000 |
| 16 May 2022 | EUR 0.2500 |
| 19 May 2021 | EUR 0.1300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.